The latest insights, ideas, and perspectives from BCG. Explore a cross-section of up-to-date content on the trends shaping the future of business and society.
Mammut CEO Heiko Schaefer and Sylvain Duranton of BCG X discuss AI's role in product and process innovation and the importance of building a culture of trust.
Companies are beginning to focus on AI’s ROI. SAP’s Thomas Saueressig and BCG’s Vikas Taneja say data quality and change management are key to value creation.
IBM’s Rob Thomas and BCG’s Sylvain Duranton discuss what’s needed to foster tech innovation and the developments that they are excited to see in 2025.
BCG’s Barry Rosenberg shares why M&A momentum, innovation for clinical and economic value, and people-centered leadership will shape this year in the field of health.
BCG’s Ashkan Afkhami discusses GenAI’s impact on trial efficiency, the challenge of scaling innovation, and why partnerships are key to driving health care transformation this year.
With a significant amount of dry powder, private equity firms can influence how research happens and where therapies are deployed—and how quickly, says BCG’s Bob Lavoie.
New AI-based tools and techniques in the field of ophthalmology are transforming how doctors do their work and patients receive care, says Alcon’s Franck Leveiller.
BCG's leading experts share what excites them most about the future of health care in 2025 and beyond.
